OmniBRx ( ): A bioprocess engineering company announced a Series A equity raise of INR 30 crore from SIDBI Venture Capital Limited (

Biotech Company OmniBRx Raises INR 30 Cr in Series A Led by SIDBI Venture Capital

Commenting on the occasion, Mr. Ravindra Patel, founder and CEO of OmniBRx Biotechnologies said “We are thankful to the team at SVCL for believing in our vision and backing us on our expansion plans”. He further added that "Scalable and Efficient bioprocessing technologies, specifically the Single-use bioreactor platforms are in high demand worldwide for the production of vaccines and other biologicals. Innovation based technology solutions from OmniBRx has potential to meet these exponentially growing market demands of biologics and vaccines.

The CellBRx Single- use Bioreactors from OmniBRx is the world’s largest and most efficient vaccine manufacturing platform for large scale vaccines and viral vector Production. OmniBRx is also the creator of world's first integrated seed train development platforms in close-loop sequentially programmed bioreactor systems” Ravindra added.

With infusion of series-A funds, OmniBRx is all set to expand their business in the overseas market. The company would also invest in adding to its capacity and build best in class manufacturing facilities to augment its production capabilities and meet growing market demands.

Sajit Kumar. Sr. VP at SIDBI Venture Capital Limited quoted “We are happy to partner with OmniBRx. We believe that their focus and deep domain knowledge will help them to penetrate the global markets. This is our third investment out of “Ubharte Sitaare Fund”, fund for MSME’s focused on scaling up in the export markets. Wishing them all the best".

Delhi based Indus Capital a boutique investment bank, founded by Mr. Santosh Patra was the exclusive financial advisor to OmniBRx for this transaction.

About OmniBRx (

OmniBRx is an Ahmedabad based Bioprocess engineering company focused on design and development of novel single-use bioreactors (SUB's) for cell culture based bioprocessing applications i.e. Vaccines, Gene therapies and biologics production. The Company was incorporated in 2016 and successfully launched their innovative products like CellBRx and MiniBRx single-use Bioreactor platforms.

About SIDBI Ventures:(

SIDBI Venture Capital Limited (SVCL), incorporated in 1999, is a wholly owned subsidiary of SIDBI (, the Apex Financial Institution in India for the MSME sector. Over the years SVCL has set-up and managed several Venture Capital Funds / AIFs, “Ubharte Sitaare Fund” is the eighth Fund set-up and managed by SVCL.

Post a Comment

Previous Post Next Post
Like this content? Sign up for our daily newsletter to get latest updates.